H

Histocell. Regenerative Medicine

24 employees

Histocell SL is a biopharmaceutical company that develops cell therapy products and novel medical devices for regenerative medicine.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Regenerative Medicine
Dermocosmetics
Tissue Engineering
Research
Cell Therapy
Wound Healing
GMP
CDMO
Health Care
Skin Care
Advanced Therapies
Medical Device
Medical Devices
biopharmaceutical
Medical
Pharmeceutical Industry

Date founded

2004

Funding rounds raised

Total raised

$4.5M

from 3 investors over 3 rounds

H

Histocell. Regenerative Medicine raised $54K on February 1, 2017

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

H

Histocell. Regenerative Medicine raised $4.5M on September 30, 2016

Investors: Seed Capital Bizkaia

H

Histocell. Regenerative Medicine raised $2.7M on April 1, 2015

Investors: ORZA GESTION Y TENENCIA DE PATRIMONIOS AIE

FAQ